Horm Metab Res 2022; 54(01): 37-41
DOI: 10.1055/a-1685-0655
Endocrine Care

Novel Classification of Acromegaly in Accordance with Immunohistochemical Subtypes: Is There Really a Clinical Relevance?

1   Division of Endocrinology, Cukurova University, Adana, Turkey
,
Fulya Odabaş
1   Division of Endocrinology, Cukurova University, Adana, Turkey
,
Sinan Sözütok
2   Division of Radiology, Cukurova University, Adana, Turkey
,
Murat Sert
1   Division of Endocrinology, Cukurova University, Adana, Turkey
,
Numan Emre Ak
3   Internal Medicine Department, Cukurova University, Adana, Turkey
,
Mehtap Evran
1   Division of Endocrinology, Cukurova University, Adana, Turkey
,
Tamer Tetiker
1   Division of Endocrinology, Cukurova University, Adana, Turkey
› Author Affiliations

Abstract

According to the recent studies, immunohistochemical subtypes of growth hormone (GH) secreting adenomas have been considered as a predictive factor in determining the clinical outcomes including biochemical, radiologic, and endocrine remission. In a 20 year-of time period, acromegaly patients who were treated and followed at the Endocrinology Department of our University Hospital were screened for the study. Of total 98 patients, 65 patients who had been operated by transsphenoidal surgery and having postoperative specimens were included. Postoperative specimens of the surgery of the patients were classified into 3 groups based on the histochemical characteristics (densely, sparsely, and mixed). Parasellar extensions of pituitary tumors were classified into the five grades according to Knosp classification. The patients were investigated and evaluated for postoperative clinical progress, remission rates, comorbidities regarding with the histopathological patterns. Of total 65 patients, 31 were classified as densely granulated (group 1), 32 were classified as sparsely granulated (group 2), and 2 patients were assessed as mixed granulated (group 3). There was no difference between groups for age and gender. Pre-treatment of adenoma size in all groups was correlated with each other and the frequency of macroadenoma (1 vs. 2, 77.4 vs. 84.3%) was higher in two groups. Although mean initial GH levels in group 1 was higher than the other groups (p=0.03), IGF1 levels (age and gender matched) were similar in each group. Adenomas in all groups demonstrated noninvasive radiological characteristics (Knosp grade 0–1–2). Ki-67 proliferation index of both groups (64.5 vs. 50%) was predominantly 1%. With a similar follow-up period, the endocrine remission rates (GH<1 μg/l) in groups were 64 vs. 69%, respectively. In conclusion, classification according to immunohistochemical subtypes of growth hormone secreting adenomas may not be a qualified parameter to evaluate patients with patterns of aggressiveness, clinical outcomes, or treatment response.



Publication History

Received: 07 July 2021

Accepted after revision: 24 October 2021

Article published online:
29 November 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany